heal-trial.org valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | HEAL |
| Description | Welcome to Toggle navigation HOME About HIE About Erythropoietin About This study Contacts HEAL Portal (Auth Req’d) Welcome to HEAL Mission: to improve the brain dev |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 128.208.192.147 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
heal-trial.org Valuation
|
US$920,874
Last updated: 2023-05-01 12:31:59
heal-trial.org has Semrush global rank of 11,493,769. heal-trial.org has an estimated worth of US$ 920,874, based on its estimated Ads revenue. heal-trial.org receives approximately 106,255 unique visitors each day. Its web server is located in United States, with IP address 128.208.192.147. According to SiteAdvisor, heal-trial.org is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$920,874 |
| Daily Ads Revenue | US$851 |
| Monthly Ads Revenue | US$25,502 |
| Yearly Ads Revenue | US$306,014 |
| Daily Unique Visitors | 7,084 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| heal-trial.org. | A | 86399 | IP: 128.208.192.147 |
| heal-trial.org. | NS | 86400 | NS Record: holly.s.uw.edu. |
| heal-trial.org. | NS | 86400 | NS Record: hanna.cac.washington.edu. |
| heal-trial.org. | NS | 86400 | NS Record: marge.cac.washington.edu. |
| heal-trial.org. | TXT | 86400 | TXT Record: Carl Riches, cgr@u |
HtmlToTextCheckTime:2023-05-01 12:31:59
| Toggle navigation HOME About HIE About Erythropoietin About This study Contacts HEAL Portal (Auth Req’d) Welcome to HEAL Mission: to improve the brain development and neurologic function of term infants with hypoxic-ischemic encephalopathy (HIE). The HEAL Trial is a randomized, double-blinded, multi-center, placebo-controlled trial designed to test the efficacy of high dose erythropoietin (Epo) for neuroprotection in term infants with hypoxic-ischemic encephalopathy (HIE). HIE is sometimes referred to as neonatal encephalopathy, or birth asphyxia. The aim of this NINDS funded trial is to assess whether multiple high doses of Epo during the first week of age will reduce the rate of death or moderate/severe motor and cognitive impairment in infants born with HIE. 500 term and near-term infants with HIE will be enrolled at over 15 centers across the U.S. Infants will be assessed at 2 years of age to see whether Epo treatment improved neurodevelopmental outcomes. Principal Investigators, |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 03:00:52 GMT Server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/5.4.16 mod_mono/3.13 Location: https://heal-trial.org Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sun, 24 Oct 2021 03:00:53 GMT Server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/5.4.16 mod_mono/3.13 Strict-Transport-Security: max-age=31536000; includeSubDomains Last-Modified: Tue, 08 Dec 2020 01:22:56 GMT ETag: "3a96-5b5e9c84e3ab6" Accept-Ranges: bytes Content-Length: 14998 X-Powered-By: Mono Content-Type: text/html; charset=UTF-8 |
heal-trial.org Whois Information
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |